telehealth for branded meds like Ozempic, Zepbound, Wegovy and Mounjaro
The new pill is priced similarly to Wegovy, with starter doses around $149 per month for cash-paying customers
With altRx, you get more than a medicationyou get a guided, supportive pathway to long lasting results
Semaglutide 2.4 mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection
Customers who incorporate it into their daily routine often report steady energy and greater control over portion sizes
A 2024 Copenhagen-based trial found that participants who maintained a supervised exercise routine after stopping liraglutide regained significantly less weight than those who relied on the medication alone